Japan’s evolving approach to market access includes a formal cost-effectiveness analysis (CEA) requirement for certain new medicines and medical devices. Introduced as part of a broader health ...
NICE, in collaboration with other international health technology assessment agencies, has published a new report which offers guidance on best practice for using surrogate endpoints in health ...
William Padula, PhD, MSc, MS, assistant professor of pharmaceutical and health economics, University of California Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, discusses the benefits ...
Sanjay Basu ([email protected]), Waymark, San Francisco, California. Atheendar S. Venkataramani, University of Pennsylvania, Philadelphia, Pennsylvania. Dean ...
The high-low method is used in cost accounting to estimate fixed and variable costs based on a business's highest and lowest levels of activity. By focusing on these extremes, the high-low method ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results